| Literature DB >> 28661451 |
Xiaowei Luo1,2, Xiuping Lin3, Limbadri Salendra4,5, Xiaoyan Pang6,7, Yu Dai8,9, Bin Yang10, Juan Liu11, Junfeng Wang12, Xuefeng Zhou13, Yonghong Liu14.
Abstract
Four new isobenzofuranones, leptosphaerins J-M (1-4), including an unusual naturally-occurring centrosymmetric dimer skeleton (1), and two new isochromenones, clearanols I-J (9-10), were obtained from a culture of a deep-sea sediment-derived fungus Leptosphaeria sp. SCSIO 41005, together with four known isobenzofuranones (5-8) and six known isochromenones (11-16). These structures were elucidated by extensive spectroscopic analyses, and absolute configurations were assigned on the basis of electronic circular dichroism and optical rotations data comparison. Additionally, the absolute configurations of the new compounds 1 and 9, together with the known one 7 with stereochemistry undetermined, were further confirmed by single crystal X-ray diffraction experiments. A plausible biosynthetic pathway of these isobenzofuranones and isochromenones was also proposed.Entities:
Keywords: Leptosphaeria sp.; clearanols; deep-sea fungi; leptosphaerins
Mesh:
Substances:
Year: 2017 PMID: 28661451 PMCID: PMC5532646 DOI: 10.3390/md15070204
Source DB: PubMed Journal: Mar Drugs ISSN: 1660-3397 Impact factor: 5.118
Figure 1Chemical structures of compounds 1–16 (* new compounds).
The 1H and 13C NMR data of compounds 1–4 (MeOD, δ in ppm, J in Hz).
| Position | 1 | 2 | 3 | 4 | ||||
|---|---|---|---|---|---|---|---|---|
| 170.5, C | - | 173.2, C | - | 172.3, C | - | 171.5, C | - | |
| 90.5, C | - | 90.0, C | - | 91.5, C | - | 90.0, C | - | |
| 114.5, C | - | 113.1, C | - | 111.4, C | - | 100.1, CH | 6.51, s | |
| 166.7, C | - | 166.2, C | - | 165.1, C | - | 168.4, C | - | |
| 100.8, CH | 6.59, s | 99.4, CH | 6.38, s | 103.1, CH | 6.36, s | 102.5, CH | 6.39, s | |
| 160.3, C | - | 158.1, C | - | 157.5, C | - | 160.4, C | - | |
| 202.9, C | - | 174.5, C | - | 71.0, CH | 4.22, q (6.5) | 72.4, CH | 3.90, q (6.5) | |
| 23.8, CH3 | 1.94, s | - | 17.3, CH3 | 0.85, d (6.5) | 17.4, CH3 | 1.05, d (6.5) | ||
| 21.1, CH3 | 1.69, s | 22.8, CH3 | 1.78, s | 21.5, CH3 | 1.71, s | 22.0, CH3 | 1.59, s | |
| 65.1, CH2 | 4.43, d (10.9) | 10.6, CH3 | 2.16, s | 11.3, CH3 | 2.09, s | - | - | |
| 4.25, d (10.9) | ||||||||
| 57.0, CH3 | 3.90, s | 56.5, CH3 | 3.82, s | - | - | 56.4, CH3 | 3.84, s | |
| 152.1, C | - | 153.3, C | - | 153.7, C | - | 153.7, C | - | |
| 104.8, C | - | 104.9, C | - | 104.1, C | - | 104.1, C | - | |
a Recorded at 500 MHz; b Recorded at 125 MHz; c Recorded at 700 MHz; d Recorded at 175 MHz; Mult.: multiple.
Figure 2Selected HMBC and COSY correlations of compounds 1–4.
Figure 3X-ray crystallographic structure of compound 1 (Gray: carbon atom; green: hydrogen atom; red: oxygen atom).
Figure 4Experimental ECD spectra of compounds 1–8 ((A) 1, 2 and 5; (B) 3, 4 and 6–8).
The 1H and 13C NMR data of compounds 9 and 10 (MeOD, δ in ppm, J in Hz).
| Position | 9 | 10 | ||
|---|---|---|---|---|
| 171.6, C | - | 171.5, C | - | |
| 82.7, CH | 4.50, overlapped | 86.1, CH | 4.26, dd (2.1, 7.7) | |
| 31.7, CH | 3.29, overlapped | 71.7, C | - | |
| 115.3, C | - | 116.2, C | - | |
| 166.1, C | - | 165.9, C | - | |
| 98.3, CH | 6.43, s | 102.2, CH | 6.28, s | |
| 164.5, C | - | 163.9, C | - | |
| 62.5, CH2 | 3.90, dd (7.0, 11.5) | 60.9, CH2 | 4.06, dd (2.1, 11.9) | |
| 3.80, dd (5.5, 11.5) | 3.85, dd (7.7, 11.9) | |||
| 12.8, CH3 | 1.07, d (7.0) | 20.6, CH3 | 1.37, s | |
| 10.1, CH3 | 2.07, s | 12.2, CH3 | 2.29, s | |
| 56.4, CH3 | 3.86, s | - | - | |
| 146.1, C | - | 147.9, C | - | |
| 100.7, C | - | 99.5, C | - | |
a Recorded at 500 MHz; b Recorded at 125 MHz; c Recorded at 700 MHz; d Recorded at 175 MHz; Mult.: multiple.
Figure 5Selected COSY, HMBC, NOSEY correlations of compounds 9 and 10.
Scheme 1Plausible biosynthetic pathways for compounds 1–16.